Occurrence of pharmaceutically acceptable anions and cations in the Cambridge Structural Database

Journal of Pharmaceutical Sciences

Volumn 94, Issue 10, 2005, Pages 2111-2120

  Haynes, Delia A ^a   Jones, William ^a   Motherwell, W D Samuel ^a,b  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^b CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE   (United Kingdom)

Author keywords

Co crystals; Crystal engineering; Crystallinity; Hydrates solvates; Polymorphism

Indexed keywords

ACETIC ACID; ADIPIC ACID; AMMONIA; AMMONIUM DERIVATIVE; ANION; ARGININE; BENZYL THIOCYANATE; BROMIDE; CATION; CHLORIDE; DIETHYLAMINE; DODECYL SULFATE; ETHYLENEDIAMINE; FORMIC ACID; GLUTARIC ACID; HEXANOIC ACID; LAURIC ACID; MALEIC ACID; MESYLIC ACID; NITRATE; OCTANOIC ACID; OLEIC ACID; OXALIC ACID; PHOSPHATE; PIPERAZINE DERIVATIVE; SULFATE; TARTARIC ACID; THIOCYANATE; TOLUENESULFONIC ACID DERIVATIVE; UNINDEXED DRUG;

CHEMICAL COMPOSITION; CRYSTAL STRUCTURE; DATA BASE; DRUG MANUFACTURE; DRUG STRUCTURE; ENGINEERING; HYDRATION; REVIEW;

EID: 27944487022     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.20441     Document Type: Note

References (19)

1. Stahl PH, Wermuth CG, editors. 2002. Handbook of pharmaceutical salts: Properties, selection and use. Weinheim/Zürich: Wiley-VCH/VHCA.
2. Gould PJ. 1986. Salt selection for basic drugs. Int J Pharm 33:201-217.
3. Bighley LD, Berge SM, Monkhouse DC. 1996. Salt forms of drugs and absorption. In: Swarbrick J, Boylan JC, editors. Encyclopaedia of pharmaceutical technology, Vol. 13. New York: Marcel Dekker, Inc. pp 453-499.
4. Alien FH. 2002. The Cambridge structural database: A quarter of a million structures and rising. Acta Crystallogr B 58:380-388.
5. Khankari RK, Grant DJW. 1995. Pharmaceutical hydrates. Therm Acta 248:61-79;
6. Vippagunta SR, Brittain HG, Grant DJW. 2001. Crystalline solids. Ad Drug Del Rev 48:3-26.
7. Brittain H, editor. 1999. Polymorphism in pharmaceutical solids. New York: Marcel Dekker;
8. Rodríguez-Spong B, Price CP, Jayasankar A, Matzger AJ, Rodríguez-Hornedo N. 2004. General principles of pharmaceutical solid polymorphism: A supramolecular perspective. Ad Drug Del Rev 56: 241-274.
9. The term co-crystal in this paper is used to describe a subset of the much larger group of multi-component crystals that includes salts, solvates and hydrates. Specifically, co-crystal here is intended to imply a crystal that contains the unionised acid or base in question in addition to at least one other molecule. These are then further subdivided as follows: neutral co-crystals-the unionised acid or base + another neutral component (not a solvent) ionic co-crystals-the unionised acid or base+ another ionic component co-crystals of salts-the unionised acid or base + a salt of the acid or base. This definition includes crystals that could be described as solvates, for example multi-component crystals containing acetic acid. For simplicity and consistency however, the term co-crystal has been used throughout.
10. Dunitz JD. 2003. Crystal and co-crystal: A second opinion. CrystEngComm 5:506.
11. Almarsson Ö, Zaworotko MJ. 2004. Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines? Chem Commun 1889-1896,
12. Trask AV, Motherwell WDS, Jones W. 2005. Pharmaceutical co-crystallization: Engineering a remedy for caffeine hydration. Cryst Growth Des 5:1013-1021.
13. See for example Harding MM. 1999. The geometry of metal-ligand interactions relevant to proteins. Acta Crystallogr D 55:1432-1443.
14. Bruno IJ, Cole JC, Edgington PR, Kessler M, Macrae CF, McCabe P, Pearson J, Taylor R. 2002. New software for searching the Cambridge Structural Database and visualizing crystal structures. Acta Crystallogr B 58:389-397.
15. Infantes L, Chisholm J, Motherwell S. 2003. Extended motifs from water and chemical functional groups in organic molecular crystals. CrystEngComm 5:480-486.
16. Desiraju GR. 1991. Hydration in organic crystals: Prediction from molecular structure. J Chem Soc Chem Commun 426-428.
17. Bernstein J. 2002. Polymorphism in molecular crystals, IUCR monographs on crystallography, Vol. 14. Oxford: Oxford University Press; Griesser UJ,
18. Burger A. 1999. Statistical aspects of the occurrence of crystal forms among organic drug substances. Abstracts, XVIII Congress and General Assembly of the International Union of Crystallography, Glasgow, Scotland
19. Dunitz JD, Gavezzotti A. 2005. Molecular recognition in organic crystals: Directed intermolecular bonds or nonlocalized bonding? Angew Chem Intl Ed 44:1766-1787.